Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker (Q74397599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

J S Goydos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A M Brumfield

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Frezza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Booth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M T Lotze

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S E Carty

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

398-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer

10 November 2019

cites work

1 reference

12 December 2020

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

12 December 2020

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice

1 reference

12 December 2020

Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state

1 reference

12 December 2020

Hybridoma growth factor

1 reference

12 December 2020

Interleukin-6 immunoreactivity in human tumors

1 reference

12 December 2020

A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain

1 reference

12 December 2020

Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production

1 reference

12 December 2020

The in vivo anti-tumor effect of human recombinant interleukin-6.

1 reference

12 December 2020

Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein

1 reference

12 December 2020

Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer

1 reference

12 December 2020

Chromosomal breakpoints in cholangiocarcinoma cell lines

1 reference

12 December 2020

Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level

1 reference

12 December 2020

Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice

1 reference

12 December 2020

Murine Tumor Cells Metastasizing Selectively in the Liver: Ability to Produce Hepatocyte-activating Cytokines Interleukin-1 and/or -6

1 reference

12 December 2020

Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery

1 reference

12 December 2020

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

12 December 2020

Interleukin-6 serum level and monocyte production in head and neck cancer

1 reference

12 December 2020

Serum interleukin-6 in long-term hemodialyzed patients

1 reference

12 December 2020

Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice

1 reference

12 December 2020

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Preoperative and postoperative cytokines in patients with cancer

1 reference

12 December 2020

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells

1 reference

12 December 2020

High levels of "complexed" interleukin-6 in human blood

1 reference

12 December 2020

Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential

1 reference

12 December 2020

Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator

1 reference

12 December 2020

Increase of plasma IL-6 concentration with age in healthy subjects

1 reference

12 December 2020

Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation

1 reference

12 December 2020

Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells

1 reference

12 December 2020

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms

1 reference

12 December 2020

Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease

1 reference

12 December 2020

Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice

1 reference

12 December 2020

Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy

1 reference

12 December 2020

Plasma cytokines after thermal injury and their relationship to infection

1 reference

12 December 2020

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer

1 reference

12 December 2020

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Elevated plasma interleukin-6 levels in patients with acute myocardial infarction

1 reference

12 December 2020

Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure

1 reference

12 December 2020

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9

1 reference

12 December 2020

Melanoma-derived interleukin 6 inhibits in vivo melanoma growth

1 reference

12 December 2020

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

12 December 2020

Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience

1 reference

12 December 2020

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

1 reference

12 December 2020

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

12 December 2020

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

1 reference

12 December 2020

In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses

1 reference

12 December 2020

Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro

1 reference

12 December 2020

Inhibition of CT-26 murine adenocarcinoma growth in the rectum of mice treated with recombinant human interleukin-6

1 reference

12 December 2020

A phase I trial of intravenous interleukin-6 in patients with advanced cancer.

1 reference

12 December 2020

Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas

1 reference

12 December 2020

Aggressive surgical resection for cholangiocarcinoma

1 reference

12 December 2020

Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease

1 reference

12 December 2020

Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.

1 reference

12 December 2020

Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells

1 reference

12 December 2020

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

1 reference

12 December 2020

10.1097/00000658-199803000-00012

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527063%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference